The Food and Drug Administration advisory committee meets on Tuesday to consider the premarket application of a new surgically implanted weight-loss device for patients with severe obesity. The device, called the Maestro Rechargeable System, works by delivering an electronic signal called VBLOC therapy to the trunks of the vagus nerve, a cranial nerve which extends from the brain stem to the … [Read more...]
You are here: Home / Archives for The Food and Drug Administration